Skip to content

Finished goods at other companies

Axogen logo
AxogenAXGN
$41.81M+43.3%
ITG
Integer HoldingsITGR
$23.36M+44.2%
ICU Medical logo
ICU MedicalICUI
$289.36M+9.9%
Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT
STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's finished goods?
Integra LifeSciences (IART) reported finished goods of $253.15M in Q1 2026.
How has Integra LifeSciences's finished goods changed year-over-year?
Integra LifeSciences's finished goods increased by 12.3% year-over-year, from $225.36M to $253.15M.
What is the long-term trend for Integra LifeSciences's finished goods?
Over 5 years (2020 to 2025), Integra LifeSciences's finished goods has grown at a 7.8% compound annual growth rate (CAGR), from $180.3M to $262.61M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.